Product Information
CLIMARA PRO PATCH is a brand product labeled by Bayer HealthCare Pharmaceuticals Inc., priced at $59.6446 per EA under NDC 50419049104. Its NADAC has been published 671 times since Nov 28, 2013.
FDA first approved this application on Nov 21, 2003.
Strength
.045; .015 mg/d; mg/d
Manufacturer
Bayer HealthCare Pharmaceuticals Inc.NDC
50419049104
Classification
Brand
Dosage Form
PATCH
Route
TRANSDERMAL
Effective Date
9/23/2026
Active Ingredients
ESTRADIOL; LEVONORGESTRELApproval Type
New Drug (NDA)
FDA Application
NDA021258FDA Approved
11/21/2003
On Market Since
11/21/2003
Pharmacological Classes
Price Statistics
The NADAC for CLIMARA PRO PATCH has been published 671 times since Nov 28, 2013, and over the history we have for it it has risen 116.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $59.6446 per EA |
|---|---|
| All-time high | $60.0442 (Jun 12, 2024) |
| All-time low | $27.5440 (Dec 18, 2013) |
| 52-week high | $59.7878 |
| 52-week low | $59.6446 |
| Median price | $53.1515 |
| Average price | $48.6917 |
| Largest weekly change | +9.9% (Oct 29, 2014) |
| Weeks tracked | 671 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Estradiol and Levonorgestrel market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Bayer HealthCare Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Estradiol and Levonorgestrel market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Estrogen class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of CLIMARA PRO PATCH?
The current National Average Drug Acquisition Cost (NADAC) for CLIMARA PRO PATCH, manufactured by Bayer HealthCare Pharmaceuticals Inc., is $59.6446 per EA (NDC 50419049104), effective Sep 30, 2026.
How has the price of CLIMARA PRO PATCH changed over time?
Over the history we have for it, the NADAC for CLIMARA PRO PATCH has risen 116.5%. It has been tracked across 671 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for CLIMARA PRO PATCH?
Since Nov 28, 2013, the NADAC for CLIMARA PRO PATCH has ranged from a low of $27.5440 (Dec 18, 2013) to a high of $60.0442 (Jun 12, 2024), with a median of $53.1515 per EA.
Are there cheaper alternatives to CLIMARA PRO PATCH?
No other NADAC-published product currently shares the active ingredient and strength of CLIMARA PRO PATCH in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures CLIMARA PRO PATCH?
CLIMARA PRO PATCH (NDC 50419049104) is labeled by Bayer HealthCare Pharmaceuticals Inc., and CMS classifies it as a brand product.